Quick Answer
TECOGEN INC. reported Total Revenue of $27.07 million for fiscal year 2025.
TECOGEN INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $27.07M +19.7% |
$22.62M -10.0% |
$25.14M +0.5% |
$25.00M +2.5% |
$24.40M -13.6% |
$28.25M -15.5% |
| Revenue (ASC 606) | $27.07M +19.7% |
$22.62M -10.0% |
$25.14M +0.5% |
$25.00M +2.5% |
$24.40M -13.6% |
$28.25M -15.5% |
| Net Income | -$8.25M -73.3% |
-$4.76M -3.5% |
-$4.60M -87.8% |
-$2.45M -166.2% |
$3.70M +160.1% |
-$6.15M -30.6% |
| Diluted EPS | -$0.30 -57.9% |
-$0.19 +0.0% |
-$0.19 -90.0% |
-$0.10 -166.7% |
$0.15 +160.0% |
-$0.25 |
| Total Assets | $36.99M +19.0% |
$31.09M +11.9% |
$27.79M -1.6% |
$28.25M -12.7% |
$32.36M +7.6% |
$30.07M -26.9% |
| Cash and Equivalents | $12.43M +130.0% |
$5.41M +300.0% |
$1.35M -29.4% |
$1.91M -47.0% |
$3.61M +142.5% |
$1.49M +69.8% |
| Stockholders Equity | $21.65M +111.6% |
$10.23M -30.6% |
$14.75M -22.8% |
$19.09M -10.0% |
$21.21M +22.5% |
$17.31M -25.6% |
| R&D Expense | $1.17M +21.3% |
$961.8K +14.5% |
$840.0K +14.6% |
$732.9K +35.2% |
$542.1K -29.4% |
$767.3K -47.4% |
| Operating Income | -$8.24M -81.8% |
-$4.53M -2.7% |
-$4.41M -87.9% |
-$2.35M -92.7% |
-$1.22M +79.5% |
-$5.96M -27.9% |
| Gross Profit | $9.82M -0.5% |
$9.87M -3.2% |
$10.20M -7.8% |
$11.07M -4.5% |
$11.59M +7.0% |
$10.83M -13.2% |
| Shares Outstanding | 29.85M +19.6% |
24.95M +0.4% |
24.85M +0.0% |
24.85M +0.0% |
24.85M +0.0% |
24.85M +0.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $7.18M | +27.6% | -1.5% |
| Revenue (ASC 606) | September 30, 2025 | $7.18M | +27.6% | -1.5% |
| Net Income | September 30, 2025 | -$2.13M | -129.0% | -45.5% |
| Diluted EPS | September 30, 2025 | -$0.07 | -75.0% | -16.7% |
| Total Assets | September 30, 2025 | $41.46M | +50.9% | +46.2% |
| Cash and Equivalents | September 30, 2025 | $15.25M | +1089.6% | +829.6% |
| Stockholders Equity | September 30, 2025 | $25.46M | +125.2% | +179.8% |
| R&D Expense | September 30, 2025 | $297.9K | +27.4% | +10.9% |
| Operating Income | September 30, 2025 | -$2.10M | -140.6% | -48.8% |
| Gross Profit | September 30, 2025 | $2.18M | -12.0% | -11.3% |
| Shares Outstanding | September 30, 2025 | 29.82M | +20.0% | +16.6% |
- TECOGEN INC. reported Total Revenue of $27.07 million for fiscal year 2025.
- TECOGEN INC. showed an increase of +19.7% in Total Revenue compared to the prior fiscal year.
- TECOGEN INC. reported Revenue (ASC 606) of $27.07 million for fiscal year 2025.
- TECOGEN INC. showed an increase of +19.7% in Revenue (ASC 606) compared to the prior fiscal year.
- TECOGEN INC. reported Net Income of -$8.25 million for fiscal year 2025.
- TECOGEN INC. showed a decrease of -73.3% in Net Income compared to the prior fiscal year.
- TECOGEN INC. reported Diluted EPS of $0.30 per share (loss) for fiscal year 2025.
- TECOGEN INC. showed a decrease of -57.9% in Diluted EPS compared to the prior fiscal year.
- TECOGEN INC. reported Total Assets of $36.99 million for fiscal year 2025.
- TECOGEN INC. showed an increase of +19.0% in Total Assets compared to the prior fiscal year.
- TECOGEN INC. reported Cash and Equivalents of $12.43 million for fiscal year 2025.
- TECOGEN INC. showed an increase of +130.0% in Cash and Equivalents compared to the prior fiscal year.
- TECOGEN INC. reported Stockholders Equity of $21.65 million for fiscal year 2025.
- TECOGEN INC. showed an increase of +111.6% in Stockholders Equity compared to the prior fiscal year.
- TECOGEN INC. reported R&D Expense of $1.17 million for fiscal year 2025.
- TECOGEN INC. showed an increase of +21.3% in R&D Expense compared to the prior fiscal year.
- TECOGEN INC. reported Operating Income of -$8.24 million for fiscal year 2025.
- TECOGEN INC. showed a decrease of -81.8% in Operating Income compared to the prior fiscal year.
- TECOGEN INC. reported Gross Profit of $9.82 million for fiscal year 2025.
- TECOGEN INC. showed a decrease of -0.5% in Gross Profit compared to the prior fiscal year.
- TECOGEN INC. reported Shares Outstanding of 29.85 million shares for fiscal year 2025.
- TECOGEN INC. showed an increase of +19.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: